Pharmacologic treatments for covid-19 patients

Interferon alpha2b vs Standard care


Hospitalized patients

Forest plots
(last update: 2022-03-04)

Summary of findings
(last update: 2022-03-17)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=297

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
N/A
Mordyk A, Infektsionnye Bolezni, 2021
Full text
Commentary
No specific funding

Interferon alpha-2b

Standard care

RCT Patients with confirmed COVID-19 (mild-moderate) admitted to three centers in Russia. N=140
Some concerns
Details

Full description

CTRI/2020/12/029855
Bhushan S, Int J Infect Dis, 2021
Full text
Commentary
Private

Interferon alpha-2b

Standard care

RCT Patients with confirmed COVID-19 (severe) admitted to 20 centers in India. N=250
Some concerns
Details

Full description

CTRI/2020/06/026087
Pandit A, Int J Infect Dis, 2021
Full text
Commentary
Private

INF alpha 2b

Standard care

RCT Patients with confirmed COVID-19 (moderate-severe) admitted to 6 centers in India N=40
Some concerns
Details

Full description